A detailed history of Premier Fund Managers LTD transactions in Care Dx, Inc. stock. As of the latest transaction made, Premier Fund Managers LTD holds 20,226 shares of CDNA stock, worth $306,828. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,226
Holding current value
$306,828
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 08, 2025

BUY
$17.64 - $25.07 $356,786 - $507,065
20,226 New
20,226 $363,000
Q4 2021

Feb 14, 2022

SELL
$41.2 - $73.6 $1.33 Million - $2.38 Million
-32,358 Reduced 42.73%
43,374 $1.96 Million
Q2 2021

Aug 05, 2021

SELL
$63.02 - $95.11 $1.3 Million - $1.96 Million
-20,576 Reduced 21.36%
75,732 $7.18 Million
Q1 2021

May 10, 2021

BUY
$57.62 - $95.6 $5.55 Million - $9.21 Million
96,308 New
96,308 $6.06 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $811M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Premier Fund Managers LTD Portfolio

Follow Premier Fund Managers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Fund Managers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Premier Fund Managers LTD with notifications on news.